Dublin, Ireland, 26 September, 2012 – ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced leadership appointments to its Asia Pacific & Latin American teams. Mr. Wei Ming Goh has been appointed Vice President, Asia Pacific and Dr. Dennis Hurley has been appointed Vice President, Latin America.
Wei Ming Goh has over 14 years’ experience within the CRO industry and a strong track record in Asia Pacific. He joins ICON from Kendle where he was Vice President, Asia Pacific, responsible for all operational activities and partner relationships within the region. Prior to this, Wei Ming spent 11 years with Quintiles, and held a number of senior management positions in operations and finance for the company’s Asian, Australian and African region. Wei Ming has also held senior roles in Asia with Autodesk, The Ask Group and Hitachi Data Systems. Wei Ming holds a Bachelor of Accountancy from the National University of Singapore and an MBA from Cranfield School of Management in the UK.
Dr. Dennis Hurley has 30 years’ experience within the drug development industry and joins ICON from INC where, as Vice President Latin America, he was responsible for building the company’s business in the region. Dennis co-founded ECA, Mexico’s largest CRO, in 1992 and expanded it to the five other major countries in Latin America. As well as his operational leadership in clinical development, Dennis has a strong background in biostatistics, process improvement and project management and has contributed significantly to a number of approved NDAs. Dennis holds a Doctor of Science (Mathematics) from the National Polytechnic Institute in Mexico and a Post Doctorate in Biostatistics from the University of North Carolina at Chapel Hill.
Commenting on the appointments, Dr. Steve Cutler, ICON’s Group President, Clinical Research Services said: “Continuing to grow our presence and expand our capabilities in Asia Pacific and Latin America is one of our strategic priorities. I’m very pleased to welcome Wei Ming and Dennis to ICON’s Latin American and Asia Pacific leadership teams. Their strong regional knowledge and experience along with their demonstrated leadership will be invaluable as we continue to grow and expand our capabilities in these important regions.”
About ICON plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has approximately 8,300 employees, operating from 82 locations in 40 countries.
Further information is available at www.iconplc.com
+44 (0)20 7067 0594